EuroPCR e-Course
Treating bicuspid valve anatomy – evidence and practice
Didier Tchétché, John Forrest, and Thomas Modine
Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent
Andreas Baumbach, Alexandra Lansky, and William Wijns
Tuesday, May 18
- Complete 2-year follow-up from the Evolut low risk trial
11:40 – 11:50 AM CET
John Forrest
Adverse Events Drop With Fuller Accounting of Evolut Low Risk Trial
Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI
EuroPCR: PCR Statement on the 2-Year Clinical Outcomes From the Evolut Low Risk Trial
- Percutaneous mitral treatment: repair
2:00 - 3:30 PM CET
Andreas Baumbach
- Percutaneous mitral treatment: replacement
3:30 - 5:00 PM CET
Andreas Baumbach
Wednesday, May 19
- One-year results from the FUTURE-II trial
11:40 - 12:00 PM CET
Alexandra Lansky
- Leading with evidence, latest clinical outcomes update for Firesorb, Firehawk and VitaFlow
1:00 - 2:00 PM CET
Alexandra Lansky and Andreas Baumbach
- Percutaneous tricuspid valve repair: how to perform it
2:15 - 3:45 PM CET
Andreas Baumbach
- Percutaneous tricuspid valve replacement: how to perform it
3:45 - 5:00 PM CET
Andreas Baumbach
Thursday, May 20
- Managing a patient with STEMI and bystander disease in the pandemic - Part 1
09:00 - 10:40 AM CET
Andreas Baumbach
- TAVI in a degenerated surgical valve
09:00 - 10:40 AM CET
Andreas Baumbach
- Managing a patient with STEMI and bystander disease in the pandemic - Part 2
10:20 - 11:40 AM CET
Andreas Baumbach
- A randomised study comparing imaging guided implantation of Orsiro and Xience - CASTLE study
11:40 - 12:00 PM CET
Alexandra Lansky
About EuroPCR
EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. Sessions will be broadcasted live.